Clofarabine-induced Capillary Leak Syndrome in a Child With Refractory Acute Lymphoblastic Leukemia

Baytan B., Ozdemir O., Gunes A. M., DÖNMEZ O.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.32, no.2, pp.144-146, 2010 (SCI-Expanded) identifier identifier identifier


Clofarabine has significant efficiency in children with relapsed or refractory leukemia. In previous pediatric trials, various adverse effects have been described. In this case, we report a child with refractory acute lymphoblastic leukemia who developed fatal capillary leak syndrome during clofarabine therapy.